Ticker
IGCCompany Name
IGC PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 6.22M | $ -6.34M | -101.99% |
3/31/2025 | $ 6.47M | $ -7.12M | -109.99% |
12/31/2024 | $ 6.41M | $ -8.81M | -137.53% |
9/30/2024 | $ 7.55M | $ -12.57M | -166.54% |
6/30/2024 | $ 8.09M | $ -13.3M | -164.54% |
3/31/2024 | $ 7.54M | $ -13M | -172.37% |
12/31/2023 | $ 9.31M | $ -14.14M | -152% |
9/30/2023 | $ 14.38M | $ -10.8M | -75.12% |
6/30/2023 | $ 13.52M | $ -10.8M | -79.85% |
3/31/2023 | $ 15.26M | $ -11.51M | -75.4% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for IGC PHARMA INC is calculated as follows: Net Inc. Cmn. [ $ -8.3M ] / Inv. Capital [ $ 24.63M ]
(=) ROIC [ -33.69% ]
Minimum
Mar 31, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.68% |
median | 3.38% |
std | 15.2% |